Measles in NSW, 2002–2011
Alexander Rosewell A B , Tracie Reinten-Reynolds A and Paula J. Spokes A
+ Author Affiliations
- Author Affiliations
A Health Protection NSW
B Corresponding author. Email: arosw@doh.health.nsw.gov.au
NSW Public Health Bulletin 23(10) 201-207 https://doi.org/10.1071/NB12085
Published: 12 December 2012
Abstract
Measles has been eliminated in NSW for more than a decade; however outbreaks associated with international travel do occur. This EpiReview describes the epidemiology of measles in NSW from 2002–2011. A total of 281 cases of measles were notified during the period, an average annual notification rate of 0.41 notifications per 100 000 population (range: 0.06–1.25). There were 139 hospitalisations recorded with a measles diagnosis in the 10-year reporting period, corresponding to a rate of 0.20 hospitalisations per 100 000 population. Of the 80 measles virus specimens genotyped, five genotypes were identified: D9 (38%), D8 (24%), D4 (16%), D5 (14%) with H1 identified less frequently (9%). No single genotype was associated with local transmission across successive years. To sustain good measles control, children should be vaccinated against measles on time through routine childhood immunisation, and all young adults who travel internationally should be vaccinated. Clinician awareness remains important in the early identification and control of measles to avoid further transmission during outbreaks and to enable the timely implementation of public health measures.
References
[1] Moss WJ, Griffin DE. Measles. Lancet 2012; 379 153–64.| Measles.Crossref | GoogleScholarGoogle Scholar |
[2] Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell 2010; 34 S1–167.
[3] Sheppeard V, Forssman B, Ferson MJ, Moreira C, Campbell-Lloyd S, Dwyer DE, et al. Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006. Commun Dis Intell 2009; 33 21–6.
[4] National Health and Medical Research Council. The Australian Immunisation Handbook. 9th ed. Canberra: Australian Government Department of Health and Ageing; 2008.
[5] Australian Government Department of Health and Ageing. Immunise Australia Program. Available at: http://www.immunise.health.gov.au/ (Cited October 2012).
[6] National Centre for Immunisation Research and Surveillance. Vaccination. National vaccination coverage estimates. Available at: http://www.ncirs.edu.au/immunisation/coverage/estimates/index.php (Cited October 2012).
[7] Macartney KK, Durrheim DN. NSW immunisation performance: continuing progress but no room for complacency. N S W Public Health Bull 2011; 22 169–70.
| NSW immunisation performance: continuing progress but no room for complacency.Crossref | GoogleScholarGoogle Scholar |
[8] Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell 2001; 25 133–6.
[9] Heywood AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009; 87 64–71.
| Elimination of endemic measles transmission in Australia.Crossref | GoogleScholarGoogle Scholar |
[10] Heath T, Burgess M, McIntyre P, Catton M. The national measles surveillance strategy. The National Centre for Disease Control Measles Elimination Advisory Committee. Commun Dis Intell 1999; 23 41–50.
[11] NSW Ministry of Health. Measles response protocol. Available at: http://www.health.nsw.gov.au/factsheets/guideline/measles.html (Cited October 2012).
[12] Australian Government Department of Health and Ageing Communicable Diseases Network Australia. Measles case definition. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_measl.htm (Cited October 2012).
[13] Jayamaha J, Binns PL, Fennell M, Ferson MJ, Newton P, Tran T, et al. Laboratory diagnosis, molecular characteristics, epidemiological and clinical features of an outbreak of measles in a low incidence population in Australia. J Clin Virol 2012; 54 168–73.
| Laboratory diagnosis, molecular characteristics, epidemiological and clinical features of an outbreak of measles in a low incidence population in Australia.Crossref | GoogleScholarGoogle Scholar |
[14] Spokes PJ, Gilmour RE. NSW Annual Vaccine-Preventable Disease Report, 2010. N S W Public Health Bull 2011; 22 171–8.
[15] Spokes PJ, Gilmour RE. NSW Annual Vaccine-Preventable Disease Report, 2009. N S W Public Health Bull 2010; 221 197–209.
[16] Communicable Diseases Report, NSW, January and February 2008. N S W Public Health Bull 2008; 19 78
[17] Communicable Diseases Report, NSW, March and April 2006. N S W Public Health Bull 2006; 17 88–94.
| Communicable Diseases Report, NSW, March and April 2006.Crossref | GoogleScholarGoogle Scholar |
[18] Communicable Diseases Report, NSW, for May 2003. N S W Public Health Bull 2003; 14 151–8.
[19] Measles virus nomenclature update: 2012. Wkly Epidemiol Rec 2012; 87 73–81.
[20] Brotherton J. EpiReview: Measles in NSW, 1991–2000. N S W Public Health Bull 2001; 12 200–4.
| EpiReview: Measles in NSW, 1991–2000.Crossref | GoogleScholarGoogle Scholar |
[21] Hull B, Dey A, Campbell-Lloyd S, Menzies RI, McIntyre PB. NSW Annual Immunisation Coverage Report, 2010. N S W Public Health Bull 2011; 22 179–95.
| NSW Annual Immunisation Coverage Report, 2010.Crossref | GoogleScholarGoogle Scholar |
[22] Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell 2008; 32 S2–67.
[23] Menzies R, McIntyre P, Beard F. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002. Commun Dis Intell 2004; 28 S1–45.
[24] Measles – United States. 2011. MMWR 2012; 61(15): 253–7. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6115a1.htm?s_cid=mm6115a1_e (Cited October 2012).
[25] Bowen AC, Ferson MJ, Palasanthiran P. Consequences of an unrecognized measles exposure in an emergency department. Emerg Med Australas 2009; 21 491–6.
| Consequences of an unrecognized measles exposure in an emergency department.Crossref | GoogleScholarGoogle Scholar |
[26] Hope K, Boyd R, Conaty S, Maywood P. Measles transmission in health care waiting rooms: implications for public health response. Western Pacific Surveillance and Reponse Journal (in press).
[27] Kohlhagen JK, Massey PD, Durrheim DN. Meeting measles elimination indicators: surveillance performance in a regional area of Australia. Western Pacific Surveillance and Response Journal 2011; 2, e1–e1.
[28] Medicine NL. of Progress Towards the 2012 Measles Elimination Goal in WHO’s Western Pacific Region, 1990–2008. Relevé épidémiologique hebdomadaire/Section d’hygiène du Secrétariat de la Société des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 2009; 84, 271–9.
[29] Progress in global measles control, 2000–2010. Wkly Epidemiol Rec 2012; 87 45–52.
[30] Rota PA, Rota JS, Redd SB, Papania MJ, Bellini WJ. Genetic analysis of measles viruses isolated in the United States between 1989 and 2001: absence of an endemic genotype since 1994. J Infect Dis 2004; 189 S160–4.
| Genetic analysis of measles viruses isolated in the United States between 1989 and 2001: absence of an endemic genotype since 1994.Crossref | GoogleScholarGoogle Scholar |
[31] Australian Bureau of Statistics 3401.0 – Overseas Arrivals and Departures, Australia, Dec 2011 Media release: Short-term resident departures reach all time high. (2012). Available at: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Previousproducts/3401.0Media%20Release1Dec%202011?opendocument&tabname%Summary&prodno=3401.0&issue=Dec%202011&num=&view= (Cited October 2012).
